| Literature DB >> 35029543 |
Laura Chioma1, Carla Bizzarri1, Martina Verzani1, Daniela Fava2,3, Mariacarolina Salerno4, Donatella Capalbo5, Chiara Guzzetti6, Laura Penta7, Luigi Di Luigi8, Natascia di Iorgi2,3, Mohamad Maghnie2,3, Sandro Loche6, Marco Cappa1.
Abstract
Objective: This retrospective study aimed to evaluate children observed for suspected precocious puberty in five Italian centers of Pediatric Endocrinology during the first wave of coronavirus disease 2019 pandemic (March-September 2020), compared to subjects observed in the same period of the previous year. Design: The study population (490 children) was divided according to the year of observation and final diagnosis: transient thelarche, non-progressive precocious puberty, central precocious puberty (CPP), or early puberty.Entities:
Keywords: COVID-19 pandemic; lockdown; physical exercise; precocious puberty; sedentary lifestyle
Year: 2022 PMID: 35029543 PMCID: PMC8859940 DOI: 10.1530/EC-21-0650
Source DB: PubMed Journal: Endocr Connect ISSN: 2049-3614 Impact factor: 3.335
Figure 1Flowchart summarizing the study design.
Anthropometric and laboratory parameters of 2019 and 2020 female populations. Parameters are expressed as mean ± s.d. if not differently indicated. Independent Student’s t-test was used to compare continuous variables. Statistical differences between prevalences in 2019 and 2020 subgroups were assessed using the chi-square test.
| Subgroups | 2019 Population | 2020 Population | ||||||
|---|---|---|---|---|---|---|---|---|
| TT | NPP | CPP | EP | TT | NPP | CPP | EP | |
| Number (%) | 31 (22.1) | 48 (34.3) | 37 (26.4)a | 24 (17.1)a | 64 (19.5) | 97 (29.6) | 135 (41.2)a | 12 (3.7)a |
| Age at consultation (years) | 6.88 ± 0.89 | 7.49 ± 0.88b | 7.58 ± 0.94 | 8.91 ± 0.45b | 7.03 ± 0.94 | 7.19 ± 0.85b | 7.39 ± 0.84 | 8.64 ± 0.44b |
| Age at the onset of pubertal signs (years) | 6.60 ± 0.77 | 7.14 ± 0.80 | 7.04 ± 0.85 | 8.28 ± 0.32 | 6.79 ± 0.96 | 6.89 ± 0.85 | 7.04 ± 0.80 | 8.32 ± 0.37 |
| Birth weight SDS | −0.05 ± 1.12 | 0.05 ± 1.09 | 0.02 ± 0.90 | −0.09 ± 0.82 | −0.18 ± 1.02 | −0.03 ± 0.95 | −0.16 ± 1.02 | −0.12 ± 0.87 |
| BMI SDS – birth weight SDS | 0.53 ± 1.49 | 0.30 ± 1.09 | 0.48 ± 1.22 | 0.53 ± 1.37 | 0.02 ±1.03 | 0.19 ± 0.99 | 0.44 ± 1.26 | 0.25 ± 1.05 |
| Height SDS | 0.57 ± 1.00 | 0.96 ± 1.16b | 1.08 ± 1.14 | 0.92 ± 0.89 | 0.43 ± 1.06 | 0.54 ± 1.13b | 0.82 ± 1.01 | 0.59 ± 1.16 |
| Weight SDS | 0.58 ± 1.01 | 0.60 ± 1.05 | 0.77 ± 1.00 | 0.67 ± 0.94 | 0.04 ± 0.99 | 0.34 ± 0.98 | 0.52 ± 1.01 | 0.26 ± 1.07 |
| BMI SDS | 0.47 ± 1.02a | 0.31 ± 1.10 | 0.51 ± 0.95 | 0.45 ± 1.01 | −0.17 ± 0.99a | 0.15 ± 1.28 | 0.24 ± 1.54 | 0.10 ± 1.05 |
| Bone age (years) | 7.73 ± 1.04 | 8.50 ± 1.31 | 9.18 ± 1.30 | 10.14 ± 1.13 | 7.61 ± 1.20 | 7.89 ± 1.09 | 8.87 ± 1.22 | 9.95 ± 1.01 |
| Bone age advance (years) | 0.75 ± 0.85 | 1.02 ± 0.89 | 1.65 ± 0.94 | 1.20 ± 1.01 | 0.63 ±1.05 | 0.75 ± 0.81 | 1.45 ± 0.94 | 1.37 ±0.87 |
| Basal FSH (IU/L) | 2.12 ± 0.91 | 1.98 ± 1.14 | 3.44 ± 1.83 | 4.66 ± 1.81 | 2.22 ± 1.18 | 2.28 ± 1.89 | 3.95 ± 2.12 | 3.76 ± 1.98 |
| Basal LH (IU/L) | 0.01 ± 0.05 | 0.10 ± 0.38 | 1.33 ± 1.64 | 2.57 ± 2.66 | 0.13 ± 0.33 | 0.09 ± 0.19 | 1.21 ± 1.72 | 0.80 ± 1.26 |
| FSH peak (IU/L) | 12.31 ± 4.26 | 10.97 ± 4.73 | 13.16 ± 4.74 | NA | 12.32 ± 4.81 | 11.96 ± 4.68 | 13.39 ± 6.08 | NA |
| LH peak (IU/L) | 3.92 ± 2.76 | 2.80 ± 1.10 | 16.09 ± 14.67 | NA | 5.07 ± 4.14 | 3.63 ± 2.13 | 17.15 ± 14.34 | NA |
| FSH/LH ratio | 4.12 ± 1.91 | 4.36 ± 1.72 | 1.32 ± 1.03 | NA | 3.33 ± 1.92 | 3.88 ± 1.77 | 1.25 ± 1.15 | NA |
| 17-beta-estradiol (pg/mL) | 0.39 ± 1.65 | 2.50 ± 5.78 | 9.05 ± 17.38 | 14.80 ± 18.45 | 0.85 ± 2.67 | 0.95 ± 3.18 | 12.13 ± 20.17 | 9.00 ± 16.53 |
| 17-OH-Progesterone (ng/mL) | 0.89 ± 0.33 | 1.02 ± 0.39 | 0.98 ± 0.46 | 0.89 ± 0.65 | 0.52 ± 0.41 | 0.59 ± 0.62 | 0.75 ± 0.55 | 0.76 ± 0.52 |
| Uterine longitudinal diameter (mm) | 31.10 ± 6.63 | 32.44 ± 5.48 | 42.89 ± 9.63 | 46.56 ± 15.85 | 33.28 ± 7.36 | 33.37 ± 5.26 | 39.48 ± 8.14 | 39.27 ± 7.91 |
aP < 0.01, bP < 0.05.
CPP, central precocious puberty; EP, early puberty; NPP, non-progressive precocious puberty; TT, transient thelarche.
Figure 2Upward mismatch between mean birth weight and BMI SDS in 2019 and 2020 subgroups (TT, transient thelarche; NPP, non-progressive precocious puberty; CPP, central precocious puberty; EP, early puberty. * P < 0.05).
Figure 3(A) Overall weekly use of electronic devices in 2019 and 2020 populations. (B) Pre-pandemic weekly use of electronic devices in 2020 subgroups (CPP, central precocious puberty; Other, transient thelarche, early puberty, and non-progressive precocious puberty subgroups).
Figure 4Overall weekly physical activity in 2019 and 2020 populations.
Figure 5(A) Pandemic weekly physical activity in 2020 subgroups. (B) Pre-pandemic weekly physical activity in 2020 subgroups (CPP, central precocious puberty; Other, transient thelarche, early puberty, and non-progressive precocious puberty subgroups).